CRO · Private company
Parexel
Track this companyFree. Adds Parexel to your Dealase workspace and tells you when its record changes.
Clinical trials2525 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials25
- A Study to Evaluate Ofirnoflast in Adults With Very Low- to Intermediate-risk Myelodysplastic Syndromes Requiring Red Blood Cell TransfusionsPHASE2 · NOT_YET_RECRUITING · started Nov 1, 2026ClinicalTrials.gov NCT07738510 · fetched Nov 12, 2026
- A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.PHASE2 · RECRUITING · started Oct 1, 2026ClinicalTrials.gov NCT07559175 · fetched Nov 12, 2026
- A Study to Investigate the Safety and Pharmacokinetics of Single- and Multiple-ascending Doses of AZD4916 in Healthy VolunteersPHASE1 · RECRUITING · started Jul 23, 2026ClinicalTrials.gov NCT06951880 · fetched Nov 12, 2026
- A Study to Evaluate the Effect of Carbamazepine or Itraconazole on Radiprodil in Healthy Adult ParticipantsPHASE1 · ACTIVE_NOT_RECRUITING · started Jun 8, 2026ClinicalTrials.gov NCT07884734 · fetched Nov 12, 2026
- Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)PHASE3 · RECRUITING · started May 5, 2026ClinicalTrials.gov NCT07509151 · fetched Nov 12, 2026
- A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy ParticipantsPHASE1 · ACTIVE_NOT_RECRUITING · started Apr 16, 2026ClinicalTrials.gov NCT07534592 · fetched Nov 12, 2026
- A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity.PHASE1 · RECRUITING · started Mar 30, 2026ClinicalTrials.gov NCT07511205 · fetched Nov 12, 2026
- A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic ImpairmentPHASE1 · RECRUITING · started Jan 6, 2026ClinicalTrials.gov NCT07343960 · fetched Nov 12, 2026
- A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy ParticipantsPHASE1 · RECRUITING · started Dec 10, 2025ClinicalTrials.gov NCT07290283 · fetched Nov 12, 2026
- A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care TherapyPHASE1 · RECRUITING · started Nov 25, 2025ClinicalTrials.gov NCT07161414 · fetched Nov 12, 2026
- Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate CancerPHASE1_PHASE2 · RECRUITING · started Oct 1, 2025ClinicalTrials.gov NCT07181161 · fetched Nov 12, 2026
- A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA MutationPHASE3 · RECRUITING · started Aug 6, 2025ClinicalTrials.gov NCT06952803 · fetched Nov 12, 2026
- A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal AdenocarcinomaPHASE2 · RECRUITING · started Jul 17, 2025ClinicalTrials.gov NCT07069712 · fetched Nov 12, 2026
- A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional CohortPHASE1 · RECRUITING · started Jun 9, 2025ClinicalTrials.gov NCT07024823 · fetched Nov 12, 2026
- A Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 in Healthy Participants.PHASE1 · ACTIVE_NOT_RECRUITING · started Jun 6, 2025ClinicalTrials.gov NCT06995820 · fetched Nov 12, 2026
- A Study of Novel Study Interventions and Combinations in Participants With Colorectal CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Mar 12, 2025ClinicalTrials.gov NCT06792695 · fetched Nov 12, 2026
- A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate CancerPHASE1 · RECRUITING · started Mar 10, 2025ClinicalTrials.gov NCT06879041 · fetched Nov 12, 2026
- A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)PHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Dec 30, 2024ClinicalTrials.gov NCT06749457 · fetched Nov 12, 2026
- A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus ErythematosusPHASE3 · ACTIVE_NOT_RECRUITING · started Jun 29, 2024ClinicalTrials.gov NCT06015737 · fetched Nov 12, 2026
- Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With AsthmaPHASE3 · RECRUITING · started May 20, 2024ClinicalTrials.gov NCT06307665 · fetched Nov 12, 2026
- A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD1705 in Participants With DyslipidemiaPHASE1 · ACTIVE_NOT_RECRUITING · started Jan 16, 2024ClinicalTrials.gov NCT06238466 · fetched Nov 12, 2026
- BCG in Combination With Durvalumab in Adult BCG-naïve, High-risk NMIBC ParticipantsPHASE3 · ACTIVE_NOT_RECRUITING · started Aug 11, 2023ClinicalTrials.gov NCT05943106 · fetched Nov 12, 2026
- A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic AsthmaPHASE3 · ACTIVE_NOT_RECRUITING · started Apr 5, 2023ClinicalTrials.gov NCT05692180 · fetched Nov 12, 2026
- A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)PHASE2 · RECRUITING · started Jul 13, 2022ClinicalTrials.gov NCT05488340 · fetched Nov 12, 2026
- Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung CancerPHASE2 · RECRUITING · started Apr 14, 2022ClinicalTrials.gov NCT05061550 · fetched Nov 12, 2026